Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             27 results found
no title author magazine year volume issue page(s) type
1 Comparative in silico analysis of two vaccine candidates for group A streptococcus predicts that they both may have similar safety profiles Shaila, Melkote S.
2007
25 18 p. 3567-3573
7 p.
article
2 Editorial Board 2007
25 18 p. CO2-
1 p.
article
3 Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy Kasperska-Zajac, Alicja
2007
25 18 p. 3595-3598
4 p.
article
4 Enhanced decision support for policy makers using a web interface to health-economic models—Illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands Hubben, G.A.A.
2007
25 18 p. 3669-3678
10 p.
article
5 Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1) Kęsik, Małgorzata
2007
25 18 p. 3619-3628
10 p.
article
6 Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine Dennehy, Maureen
2007
25 18 p. 3646-3657
12 p.
article
7 Formaldehyde treatment increases the immunogenicity and decreases the toxicity of Haemophilus ducreyi cytolethal distending toxin Lagergård, Teresa
2007
25 18 p. 3606-3614
9 p.
article
8 Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine Devlin, Joanne M.
2007
25 18 p. 3561-3566
6 p.
article
9 Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo Khan, Mohammad A.H.
2007
25 18 p. 3544-3553
10 p.
article
10 Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations Pinitkiatisakul, Sunan
2007
25 18 p. 3658-3668
11 p.
article
11 Impact of hepatitis A vaccination on health care utilization in the United States, 1996–2004 Zhou, Fangjun
2007
25 18 p. 3581-3587
7 p.
article
12 Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model Ninomiya, Ai
2007
25 18 p. 3554-3560
7 p.
article
13 Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis Kajikawa, Akinobu
2007
25 18 p. 3599-3605
7 p.
article
14 Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection Mallick, A.I.
2007
25 18 p. 3692-3704
13 p.
article
15 Mathematical model of the antibody response to hepatitis B vaccines: Implications for reduced schedules Wilson, Jamie N.
2007
25 18 p. 3705-3712
8 p.
article
16 Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine Grunow, Roland
2007
25 18 p. 3679-3683
5 p.
article
17 Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell walls Moorthy, G.
2007
25 18 p. 3636-3645
10 p.
article
18 Potential use of an unencapsulated and aromatic amino acid-auxotrophic Streptococcus suis mutant as a live attenuated vaccine in swine Fittipaldi, Nahuel
2007
25 18 p. 3524-3535
12 p.
article
19 Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine Zeng, Mingtao
2007
25 18 p. 3588-3594
7 p.
article
20 Seroprevalence of rubella among Jordanian women of childbearing age Jarour, Najwa
2007
25 18 p. 3615-3618
4 p.
article
21 Some aspects of the recombinantly expressed humanised superagonist anti-CD28 mAb, TGN1412 trial catastrophe lessons to safeguard mAbs and vaccine trials Mehrishi, Jitendra N.
2007
25 18 p. 3517-3523
7 p.
article
22 Sustained measles elimination in Australia and priorities for long term maintenance Gidding, Heather F.
2007
25 18 p. 3574-3580
7 p.
article
23 The antigenicity of a Plasmodium vivax reticulocyte binding protein-1 (PvRBP1) recombinant fragment in humans and its immunogenicity and protection studies in Aotus monkeys Rojas Caraballo, Jose
2007
25 18 p. 3713-3721
9 p.
article
24 The PGRS domain of Mycobacterium tuberculosis Campuzano, Jaime
2007
25 18 p. 3722-3729
8 p.
article
25 Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): Protective efficacy in a double-blind, placebo-controlled challenge study McKenzie, Robin
2007
25 18 p. 3684-3691
8 p.
article
26 Vaccination of horses against strangles using recombinant antigens from Streptococcus equi Waller, Andrew
2007
25 18 p. 3629-3635
7 p.
article
27 Vaccine safety perceptions and experience with adverse events following immunization in Kazakhstan and Uzbekistan: A summary of key informant interviews and focus groups Fowler, Gabrielle L.
2007
25 18 p. 3536-3543
8 p.
article
                             27 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands